HENRY SCHEIN INC (HSIC)
US8064071025 - Common Stock
Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 109 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HSIC get a neutral evaluation. Nothing too spectacular is happening here. HSIC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
In the past year HSIC had a positive cash flow from operations.
Each year in the past 5 years HSIC has been profitable.
HSIC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HSIC has a better Return On Assets (2.96%) than 71.30% of its industry peers.
Looking at the Return On Equity, with a value of 8.96%, HSIC is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
HSIC has a better Return On Invested Capital (5.64%) than 65.74% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HSIC is in line with the industry average of 8.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.96% | ||
| ROIC | 5.64% |
ROA(3y)5.88%
ROA(5y)6.51%
ROE(3y)15.14%
ROE(5y)16.13%
ROIC(3y)9.29%
ROIC(5y)9.35%
1.3 Margins
With a decent Profit Margin value of 2.51%, HSIC is doing good in the industry, outperforming 70.37% of the companies in the same industry.
HSIC's Profit Margin has declined in the last couple of years.
HSIC has a Operating Margin of 4.86%. This is in the better half of the industry: HSIC outperforms 62.96% of its industry peers.
In the last couple of years the Operating Margin of HSIC has declined.
HSIC has a Gross Margin (31.59%) which is in line with its industry peers.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.86% | ||
| PM (TTM) | 2.51% | ||
| GM | 31.59% |
OM growth 3Y1.22%
OM growth 5Y-4.64%
PM growth 3Y-5.48%
PM growth 5Y-9.94%
GM growth 3Y4.01%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HSIC has less shares outstanding than it did 1 year ago.
HSIC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HSIC is higher compared to a year ago.
2.2 Solvency
HSIC has an Altman-Z score of 2.74. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
HSIC's Altman-Z score of 2.74 is fine compared to the rest of the industry. HSIC outperforms 66.67% of its industry peers.
HSIC has a debt to FCF ratio of 6.79. This is a slightly negative value and a sign of low solvency as HSIC would need 6.79 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.79, HSIC is in the better half of the industry, outperforming 68.52% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that HSIC is somewhat dependend on debt financing.
HSIC has a Debt to Equity ratio of 0.73. This is comparable to the rest of the industry: HSIC outperforms 45.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 6.79 | ||
| Altman-Z | 2.74 |
ROIC/WACC0.68
WACC8.29%
2.3 Liquidity
A Current Ratio of 1.42 indicates that HSIC should not have too much problems paying its short term obligations.
The Current ratio of HSIC (1.42) is comparable to the rest of the industry.
A Quick Ratio of 0.82 indicates that HSIC may have some problems paying its short term obligations.
HSIC's Quick ratio of 0.82 is on the low side compared to the rest of the industry. HSIC is outperformed by 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
HSIC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.63%.
The Earnings Per Share has been growing slightly by 1.68% on average over the past years.
HSIC shows a decrease in Revenue. In the last year, the revenue decreased by -1.53%.
HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)-16.63%
EPS 3Y14.86%
EPS 5Y1.68%
EPS Q2Q%-7.58%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y6.84%
Revenue growth 5Y5.55%
Sales Q2Q%0.38%
3.2 Future
The Earnings Per Share is expected to grow by 8.81% on average over the next years. This is quite good.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.96% on average per year.
EPS Next Y8.22%
EPS Next 2Y8.42%
EPS Next 3Y8.7%
EPS Next 5Y8.81%
Revenue Next Year3.79%
Revenue Next 2Y3.79%
Revenue Next 3Y3.86%
Revenue Next 5Y3.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.58 indicates a correct valuation of HSIC.
Based on the Price/Earnings ratio, HSIC is valued a bit cheaper than the industry average as 75.93% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.73. HSIC is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 13.20 indicates a correct valuation of HSIC.
Based on the Price/Forward Earnings ratio, HSIC is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of HSIC to the average of the S&P500 Index (22.83), we can say HSIC is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.58 | ||
| Fwd PE | 13.2 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 68.52% of the companies listed in the same industry.
73.15% of the companies in the same industry are more expensive than HSIC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.26 | ||
| EV/EBITDA | 11.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HSIC may justify a higher PE ratio.
PEG (NY)2.02
PEG (5Y)9.86
EPS Next 2Y8.42%
EPS Next 3Y8.7%
5. Dividend
5.1 Amount
HSIC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HENRY SCHEIN INC
NASDAQ:HSIC (12/20/2024, 8:17:11 PM)
After market: 69.82 0 (0%)69.82
+0.87 (+1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.67%
Inst Owner Change5.29%
Ins Owners0.88%
Ins Owner Change-1.89%
Market Cap8.71B
Analysts72
Price Target75.79 (8.55%)
Short Float %5.23%
Short Ratio3.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.73%
Min EPS beat(2)-1.06%
Max EPS beat(2)2.52%
EPS beat(4)2
Avg EPS beat(4)0.26%
Min EPS beat(4)-6.72%
Max EPS beat(4)6.28%
EPS beat(8)3
Avg EPS beat(8)-0.71%
EPS beat(12)5
Avg EPS beat(12)0.78%
EPS beat(16)8
Avg EPS beat(16)4.9%
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)-3.82%
Revenue beat(4)0
Avg Revenue beat(4)-3.86%
Min Revenue beat(4)-5.88%
Max Revenue beat(4)-2.58%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)1
Avg Revenue beat(12)-2.72%
Revenue beat(16)5
Avg Revenue beat(16)-1.02%
PT rev (1m)0.81%
PT rev (3m)2.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.54%
EPS NY rev (1m)0.09%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.58 | ||
| Fwd PE | 13.2 | ||
| P/S | 0.7 | ||
| P/FCF | 22.26 | ||
| P/OCF | 14.22 | ||
| P/B | 2.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.81 |
EPS(TTM)4.21
EY6.03%
EPS(NY)5.29
Fwd EY7.58%
FCF(TTM)3.14
FCFY4.49%
OCF(TTM)4.91
OCFY7.03%
SpS100.25
BVpS28.1
TBVpS-12.7
PEG (NY)2.02
PEG (5Y)9.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.96% | ||
| ROCE | 7.92% | ||
| ROIC | 5.64% | ||
| ROICexc | 5.73% | ||
| ROICexgc | 15.12% | ||
| OM | 4.86% | ||
| PM (TTM) | 2.51% | ||
| GM | 31.59% | ||
| FCFM | 3.13% |
ROA(3y)5.88%
ROA(5y)6.51%
ROE(3y)15.14%
ROE(5y)16.13%
ROIC(3y)9.29%
ROIC(5y)9.35%
ROICexc(3y)9.48%
ROICexc(5y)9.63%
ROICexgc(3y)22.14%
ROICexgc(5y)23.01%
ROCE(3y)12.26%
ROCE(5y)12.29%
ROICexcg growth 3Y-5.09%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-6.61%
ROICexc growth 5Y-4.38%
OM growth 3Y1.22%
OM growth 5Y-4.64%
PM growth 3Y-5.48%
PM growth 5Y-9.94%
GM growth 3Y4.01%
GM growth 5Y0.25%
F-Score6
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 6.79 | ||
| Debt/EBITDA | 2.84 | ||
| Cap/Depr | 76.47% | ||
| Cap/Sales | 1.77% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 68.23% | ||
| Profit Quality | 124.52% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 2.74 |
F-Score6
WACC8.29%
ROIC/WACC0.68
Cap/Depr(3y)52.8%
Cap/Depr(5y)45.18%
Cap/Sales(3y)0.97%
Cap/Sales(5y)0.83%
Profit Quality(3y)89.74%
Profit Quality(5y)98.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.63%
EPS 3Y14.86%
EPS 5Y1.68%
EPS Q2Q%-7.58%
EPS Next Y8.22%
EPS Next 2Y8.42%
EPS Next 3Y8.7%
EPS Next 5Y8.81%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y6.84%
Revenue growth 5Y5.55%
Sales Q2Q%0.38%
Revenue Next Year3.79%
Revenue Next 2Y3.79%
Revenue Next 3Y3.86%
Revenue Next 5Y3.96%
EBIT growth 1Y-27.01%
EBIT growth 3Y8.14%
EBIT growth 5Y0.65%
EBIT Next Year20.92%
EBIT Next 3Y11.59%
EBIT Next 5Y8.25%
FCF growth 1Y-25.86%
FCF growth 3Y-17.14%
FCF growth 5Y-12.49%
OCF growth 1Y-2.03%
OCF growth 3Y-5.84%
OCF growth 5Y-6%